Gossamer Bio Stock Alpha and Beta Analysis

GOSS Stock  USD 0.70  0.04  6.06%   
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Gossamer Bio. It also helps investors analyze the systematic and unsystematic risks associated with investing in Gossamer Bio over a specified time horizon. Remember, high Gossamer Bio's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Gossamer Bio's market risk premium analysis include:
Beta
0.52
Alpha
(0.41)
Risk
3.4
Sharpe Ratio
(0.09)
Expected Return
(0.29)
Please note that although Gossamer Bio alpha is a measure of relative return and represented here as a single number, it indicates the percentage above or below your selected benchmark (i.e., Dow Jones Industrial index.) So in this particular case, Gossamer Bio did 0.41  worse than the index. Remember, a high alpha is always good. Beta, on the other hand, measures the volatility (or risk) of an investment. It is an indication of Gossamer Bio stock's relative risk over its benchmark. Gossamer Bio has a beta of 0.52  . As returns on the market increase, Gossamer Bio's returns are expected to increase less than the market. However, during the bear market, the loss of holding Gossamer Bio is expected to be smaller as well. At this time, Gossamer Bio's Price Book Value Ratio is comparatively stable compared to the past year. Price Fair Value is likely to gain to 2.33 in 2024, whereas Tangible Book Value Per Share is likely to drop 0.39 in 2024.

Enterprise Value

613.32 Million

Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
  
Check out Gossamer Bio Backtesting, Gossamer Bio Valuation, Gossamer Bio Correlation, Gossamer Bio Hype Analysis, Gossamer Bio Volatility, Gossamer Bio History and analyze Gossamer Bio Performance.
For more information on how to buy Gossamer Stock please use our How to Invest in Gossamer Bio guide.

Gossamer Bio Market Premiums

Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Gossamer Bio market risk premium is the additional return an investor will receive from holding Gossamer Bio long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Gossamer Bio. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Gossamer Bio's performance over market.
α-0.41   β0.52

Gossamer Bio expected buy-and-hold returns

Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Gossamer Bio's Buy-and-hold return. Our buy-and-hold chart shows how Gossamer Bio performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.

Gossamer Bio Market Price Analysis

Market price analysis indicators help investors to evaluate how Gossamer Bio stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Gossamer Bio shares will generate the highest return on investment. By understating and applying Gossamer Bio stock market price indicators, traders can identify Gossamer Bio position entry and exit signals to maximize returns.

Gossamer Bio Return and Market Media

The median price of Gossamer Bio for the period between Sat, Aug 31, 2024 and Fri, Nov 29, 2024 is 0.91 with a coefficient of variation of 10.9. The daily time series for the period is distributed with a sample standard deviation of 0.1, arithmetic mean of 0.9, and mean deviation of 0.07. The Stock received substential amount of media coverage during this period.
 Price Growth (%)  
       Timeline  
1
Gossamer Bio Has One More Shot On Goal And Is Not Likely To Miss - Seeking Alpha
09/10/2024
2
Gossamer Bio, Inc. Short Interest Down 5.8 percent in September - MarketBeat
09/30/2024
3
Gossamer Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635
10/07/2024
4
3 US Penny Stocks With Market Caps Under 900M To Consider - Simply Wall St
10/28/2024
5
Gossamer Bio Q3 Earnings Snapshot
11/07/2024
6
After Plunging -15.92 percent in 4 Weeks, Heres Why the Trend Might Reverse for Gossamer Bio
11/14/2024
7
Acquisition by Aranda Richard of 157500 shares of Gossamer Bio subject to Rule 16b-3
11/26/2024

About Gossamer Bio Beta and Alpha

For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Gossamer or other stocks. Alpha measures the amount that position in Gossamer Bio has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.

Gossamer Bio Upcoming Company Events

As portrayed in its financial statements, the presentation of Gossamer Bio's financial position is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Gossamer Bio's leadership is honest, while the outside auditors are strict and uncompromising. Whatever the case, investors should always follow all of Gossamer Bio's public filing events to personally review all filings and be reasonable and skeptical to interpret all of the financial statements of Gossamer Bio. Please utilize our Beneish M Score to check the likelihood of Gossamer Bio's management manipulating its earnings.
15th of March 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
15th of March 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View

Build Portfolio with Gossamer Bio

Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.

Build Diversified Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Additional Tools for Gossamer Stock Analysis

When running Gossamer Bio's price analysis, check to measure Gossamer Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Gossamer Bio is operating at the current time. Most of Gossamer Bio's value examination focuses on studying past and present price action to predict the probability of Gossamer Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Gossamer Bio's price. Additionally, you may evaluate how the addition of Gossamer Bio to your portfolios can decrease your overall portfolio volatility.